Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients

Background Several studies have addressed the prevalence of Toxoplasma gondii (T. gondii), among Parkinson’s disease (PD) patients in different countries, and the potential association between the infection and PD; the results of these studies were conflicting. The study aims to investigate the prev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Iraqi journal of pharmaceutical sciences 2021-12, Vol.30 (2), p.99-105
Hauptverfasser: Merdaw, Maysoon Abdul zahra, Kasim, Ali Abdulhussain, Salih, Mahmood Kahtan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 105
container_issue 2
container_start_page 99
container_title Iraqi journal of pharmaceutical sciences
container_volume 30
creator Merdaw, Maysoon Abdul zahra
Kasim, Ali Abdulhussain
Salih, Mahmood Kahtan
description Background Several studies have addressed the prevalence of Toxoplasma gondii (T. gondii), among Parkinson’s disease (PD) patients in different countries, and the potential association between the infection and PD; the results of these studies were conflicting. The study aims to investigate the prevalence of Toxoplasma infection among sample of Iraqi PD patients. Also, to examine the potential association of age, PD duration, gender, smoking habit, zone of residence and family history of PD, with the prevalence of Toxoplasma infection in PD patients. Patients and Methods Seventy-four PD patients attaining Dr. Saad Al-Witry Neuroscience Hospital in Baghdad/ Iraq for routine follow up, from different Iraqi governorates, were enrolled in this cross-sectional study. Detection of T. gondii was performed by detection of anti-Toxoplasma IgG and IgM antibodies in serum by ELISA method. Results The frequency rate of anti-Toxoplasma IgG antibodies in Iraqi PD patients was 43.2% (32/74); while, none of the participants was seropositive for anti-Toxoplasma IgM antibody. Age, PD duration, smoking habit and zone of residences were not shown to be risk factors for Toxoplasma infection in PD patients (P>0.05); meanwhile, female gender and positive family history of PD were shown to have a protective effect ((OR, 0.309; 95% CI, 0.099-0.966; P= 0.043) and (OR, 0.162; 95% CI, 0.037-0.705; P=0.015); respectively). Conclusions The prevalence rate of Toxoplasma infection in Iraqi PD patients is 43.2%, female gender and positive family history of PD might protect against Toxoplasma infection in PD patients. Key words: Iraq, Neurodegeneration, Parkinson’s disease, Prevalence, Toxoplasma gondii
doi_str_mv 10.31351/vol30iss2pp99-105
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_31351_vol30iss2pp99_105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_31351_vol30iss2pp99_105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c113t-adb07dbe78af659dcffcda13b2ca230810f28e57007f939cc0a12c87923a9bbb3</originalsourceid><addsrcrecordid>eNpVkM1KAzEUhYMoWGpfwFVeYDQ_k2aylKq1WFCwroebTALBaTLmDkV3voav55O0qAtdncP54Cw-Qs45u5BcKn65y71kEVEMgzEVZ-qITIQSvDpAcfynn5IZYrSsrnUt-JxNyP2TL3kofge9T87THOgmv-WhB9wCXebUxUhjoo9QXmLCnL4-PpFeR_SAnq4KvMYDG6NPI56RkwA9-tlvTsnz7c1mcVetH5arxdW6cpzLsYLOMt1ZrxsIc2U6F4LrgEsrHAjJGs6CaLzSjOlgpHGOAReu0UZIMNZaOSXi59eVjFh8aIcSt1DeW87abyPtPyOHWck9-tlY_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Merdaw, Maysoon Abdul zahra ; Kasim, Ali Abdulhussain ; Salih, Mahmood Kahtan</creator><creatorcontrib>Merdaw, Maysoon Abdul zahra ; Kasim, Ali Abdulhussain ; Salih, Mahmood Kahtan</creatorcontrib><description>Background Several studies have addressed the prevalence of Toxoplasma gondii (T. gondii), among Parkinson’s disease (PD) patients in different countries, and the potential association between the infection and PD; the results of these studies were conflicting. The study aims to investigate the prevalence of Toxoplasma infection among sample of Iraqi PD patients. Also, to examine the potential association of age, PD duration, gender, smoking habit, zone of residence and family history of PD, with the prevalence of Toxoplasma infection in PD patients. Patients and Methods Seventy-four PD patients attaining Dr. Saad Al-Witry Neuroscience Hospital in Baghdad/ Iraq for routine follow up, from different Iraqi governorates, were enrolled in this cross-sectional study. Detection of T. gondii was performed by detection of anti-Toxoplasma IgG and IgM antibodies in serum by ELISA method. Results The frequency rate of anti-Toxoplasma IgG antibodies in Iraqi PD patients was 43.2% (32/74); while, none of the participants was seropositive for anti-Toxoplasma IgM antibody. Age, PD duration, smoking habit and zone of residences were not shown to be risk factors for Toxoplasma infection in PD patients (P&gt;0.05); meanwhile, female gender and positive family history of PD were shown to have a protective effect ((OR, 0.309; 95% CI, 0.099-0.966; P= 0.043) and (OR, 0.162; 95% CI, 0.037-0.705; P=0.015); respectively). Conclusions The prevalence rate of Toxoplasma infection in Iraqi PD patients is 43.2%, female gender and positive family history of PD might protect against Toxoplasma infection in PD patients. Key words: Iraq, Neurodegeneration, Parkinson’s disease, Prevalence, Toxoplasma gondii</description><identifier>ISSN: 2521-3512</identifier><identifier>EISSN: 2521-3512</identifier><identifier>DOI: 10.31351/vol30iss2pp99-105</identifier><language>eng</language><ispartof>Iraqi journal of pharmaceutical sciences, 2021-12, Vol.30 (2), p.99-105</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Merdaw, Maysoon Abdul zahra</creatorcontrib><creatorcontrib>Kasim, Ali Abdulhussain</creatorcontrib><creatorcontrib>Salih, Mahmood Kahtan</creatorcontrib><title>Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients</title><title>Iraqi journal of pharmaceutical sciences</title><description>Background Several studies have addressed the prevalence of Toxoplasma gondii (T. gondii), among Parkinson’s disease (PD) patients in different countries, and the potential association between the infection and PD; the results of these studies were conflicting. The study aims to investigate the prevalence of Toxoplasma infection among sample of Iraqi PD patients. Also, to examine the potential association of age, PD duration, gender, smoking habit, zone of residence and family history of PD, with the prevalence of Toxoplasma infection in PD patients. Patients and Methods Seventy-four PD patients attaining Dr. Saad Al-Witry Neuroscience Hospital in Baghdad/ Iraq for routine follow up, from different Iraqi governorates, were enrolled in this cross-sectional study. Detection of T. gondii was performed by detection of anti-Toxoplasma IgG and IgM antibodies in serum by ELISA method. Results The frequency rate of anti-Toxoplasma IgG antibodies in Iraqi PD patients was 43.2% (32/74); while, none of the participants was seropositive for anti-Toxoplasma IgM antibody. Age, PD duration, smoking habit and zone of residences were not shown to be risk factors for Toxoplasma infection in PD patients (P&gt;0.05); meanwhile, female gender and positive family history of PD were shown to have a protective effect ((OR, 0.309; 95% CI, 0.099-0.966; P= 0.043) and (OR, 0.162; 95% CI, 0.037-0.705; P=0.015); respectively). Conclusions The prevalence rate of Toxoplasma infection in Iraqi PD patients is 43.2%, female gender and positive family history of PD might protect against Toxoplasma infection in PD patients. Key words: Iraq, Neurodegeneration, Parkinson’s disease, Prevalence, Toxoplasma gondii</description><issn>2521-3512</issn><issn>2521-3512</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkM1KAzEUhYMoWGpfwFVeYDQ_k2aylKq1WFCwroebTALBaTLmDkV3voav55O0qAtdncP54Cw-Qs45u5BcKn65y71kEVEMgzEVZ-qITIQSvDpAcfynn5IZYrSsrnUt-JxNyP2TL3kofge9T87THOgmv-WhB9wCXebUxUhjoo9QXmLCnL4-PpFeR_SAnq4KvMYDG6NPI56RkwA9-tlvTsnz7c1mcVetH5arxdW6cpzLsYLOMt1ZrxsIc2U6F4LrgEsrHAjJGs6CaLzSjOlgpHGOAReu0UZIMNZaOSXi59eVjFh8aIcSt1DeW87abyPtPyOHWck9-tlY_g</recordid><startdate>20211209</startdate><enddate>20211209</enddate><creator>Merdaw, Maysoon Abdul zahra</creator><creator>Kasim, Ali Abdulhussain</creator><creator>Salih, Mahmood Kahtan</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20211209</creationdate><title>Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients</title><author>Merdaw, Maysoon Abdul zahra ; Kasim, Ali Abdulhussain ; Salih, Mahmood Kahtan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c113t-adb07dbe78af659dcffcda13b2ca230810f28e57007f939cc0a12c87923a9bbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merdaw, Maysoon Abdul zahra</creatorcontrib><creatorcontrib>Kasim, Ali Abdulhussain</creatorcontrib><creatorcontrib>Salih, Mahmood Kahtan</creatorcontrib><collection>CrossRef</collection><jtitle>Iraqi journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merdaw, Maysoon Abdul zahra</au><au>Kasim, Ali Abdulhussain</au><au>Salih, Mahmood Kahtan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients</atitle><jtitle>Iraqi journal of pharmaceutical sciences</jtitle><date>2021-12-09</date><risdate>2021</risdate><volume>30</volume><issue>2</issue><spage>99</spage><epage>105</epage><pages>99-105</pages><issn>2521-3512</issn><eissn>2521-3512</eissn><abstract>Background Several studies have addressed the prevalence of Toxoplasma gondii (T. gondii), among Parkinson’s disease (PD) patients in different countries, and the potential association between the infection and PD; the results of these studies were conflicting. The study aims to investigate the prevalence of Toxoplasma infection among sample of Iraqi PD patients. Also, to examine the potential association of age, PD duration, gender, smoking habit, zone of residence and family history of PD, with the prevalence of Toxoplasma infection in PD patients. Patients and Methods Seventy-four PD patients attaining Dr. Saad Al-Witry Neuroscience Hospital in Baghdad/ Iraq for routine follow up, from different Iraqi governorates, were enrolled in this cross-sectional study. Detection of T. gondii was performed by detection of anti-Toxoplasma IgG and IgM antibodies in serum by ELISA method. Results The frequency rate of anti-Toxoplasma IgG antibodies in Iraqi PD patients was 43.2% (32/74); while, none of the participants was seropositive for anti-Toxoplasma IgM antibody. Age, PD duration, smoking habit and zone of residences were not shown to be risk factors for Toxoplasma infection in PD patients (P&gt;0.05); meanwhile, female gender and positive family history of PD were shown to have a protective effect ((OR, 0.309; 95% CI, 0.099-0.966; P= 0.043) and (OR, 0.162; 95% CI, 0.037-0.705; P=0.015); respectively). Conclusions The prevalence rate of Toxoplasma infection in Iraqi PD patients is 43.2%, female gender and positive family history of PD might protect against Toxoplasma infection in PD patients. Key words: Iraq, Neurodegeneration, Parkinson’s disease, Prevalence, Toxoplasma gondii</abstract><doi>10.31351/vol30iss2pp99-105</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2521-3512
ispartof Iraqi journal of pharmaceutical sciences, 2021-12, Vol.30 (2), p.99-105
issn 2521-3512
2521-3512
language eng
recordid cdi_crossref_primary_10_31351_vol30iss2pp99_105
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
title Seroprevalence of Toxoplasma Gondii in Parkinson’s Disease Iraqi Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T14%3A13%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seroprevalence%20of%20Toxoplasma%20Gondii%20in%20Parkinson%E2%80%99s%20Disease%20Iraqi%20Patients&rft.jtitle=Iraqi%20journal%20of%20pharmaceutical%20sciences&rft.au=Merdaw,%20Maysoon%20Abdul%20zahra&rft.date=2021-12-09&rft.volume=30&rft.issue=2&rft.spage=99&rft.epage=105&rft.pages=99-105&rft.issn=2521-3512&rft.eissn=2521-3512&rft_id=info:doi/10.31351/vol30iss2pp99-105&rft_dat=%3Ccrossref%3E10_31351_vol30iss2pp99_105%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true